BillionToOne (BLLN) Total Non-Current Liabilities (2024 - 2025)
BillionToOne's (BLLN) quarterly Total Non-Current Liabilities came in at $152.5 million in Q4 2025, up 15.97% year-over-year from $131.5 million in Q4 2024, and up 6.47% quarter-over-quarter from $143.3 million in Q3 2025.
Powered by 
Analysis
BillionToOne (BLLN) Total Non-Current Liabilities (2024 - 2025) Analysis & Trends
BillionToOne has disclosed Total Non-Current Liabilities across 2 years of filings, most recently posting $152.5 million for Q4 2025.
- In Q4 2025, Total Non-Current Liabilities rose 15.97% year-over-year to $152.5 million; the TTM figure through Dec 2025 stood at $152.5 million (up 15.97% YoY), while the FY2025 annual figure was $152.5 million, up 15.97% from the prior year.
- Total Non-Current Liabilities came in at $152.5 million for Q4 2025 at BillionToOne, up from $143.3 million in the prior quarter.
- In the past five years, Total Non-Current Liabilities ranged from a high of $152.5 million in Q4 2025 to a low of $131.5 million in Q4 2024.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Natera | 49.39 Bn | 48.29 Bn | 486.15 Mn | 715.49 Mn |
| 2 | Quest Diagnostics | 27.49 Bn | 26.86 Bn | 1.03 Bn | 8.06 Bn |
| 3 | Labcorp Holdings | 26.51 Bn | 26.37 Bn | 1.11 Bn | 9.19 Bn |
| 4 | Guardant Health | 23.17 Bn | 22.12 Bn | 219.03 Mn | 2.01 Bn |
| 5 | Tempus AI | 12.59 Bn | 11.77 Bn | 274.25 Mn | 1.86 Bn |
| 6 | Caris Life Sciences | 8.01 Bn | 7.22 Bn | 182.38 Mn | 584.41 Mn |
| 7 | Sotera Health | 5.53 Bn | 5.17 Bn | 177.96 Mn | 2.59 Bn |
| 8 | BillionToOne | 4.80 Bn | 4.25 Bn | 77.11 Mn | - |
| 9 | Adaptive Biotechnologies | 4.40 Bn | 4.05 Bn | 51.39 Mn | 490.00 Mn |
| 10 | iRhythm Holdings | 3.68 Bn | 3.08 Bn | 163.21 Mn | 906.54 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 152.55 Mn |
| Sep 30, 2025 | 143.28 Mn |
| Dec 31, 2024 | 131.54 Mn |